Investor Presentaiton
COVID - 19 Response
Q2 FY21 saw normal levels of production, with rigorous safety, hygiene and cleaning protocols at all
Manufacturing Facilities. Operations were at a steady state at Corporate Office and R&D center with all the
scientist working onsite.
A thorough thermal scanning
and sanitization protocol was
Safety and wellbeing introduced at all the plants and
of our people
offices. Monitoring employees
for signs & symptoms through
voluntary disclosure.
2m
Social distancing in
canteens and in
company and in
transport.
Laurus Labs Priorities in the uncertain times of Pandemic
Vehicles transporting
employees were sanitized
thrice a day. Transport
shift system to reduce
density on site.
Regular Testing was
also introduced for
employees.
Work from home where
possible and other
protection measures for
employees allowed
operations to return to
normal levels.
Focus on Operating
efficiencies
Resilient supply chain
in place.
We continue to have normal
supply levels for all our products
and believe it will remain at
normal levels throughout the
pandemic.
Manufacturing
facilities currently
operating at almost
full capacity
Laurus Labs contributions to help the government respond to
Covid-19 containment ~ Rs. 55 million for H1 FY21
We provided financial incentives to our Employees
Laurus Labs Donated 480,000 doses of Hydroxychloroquine
(HCQ) to the governments of Telangana, Andhra Pradesh, and
Kerala in addition to a financial contribution of Rs. 5 million to
each AP & Telangana States.
Provided food to the needy and poor. Also provided PPES
to frontline workers in the police department and medical
colleges who are treating Covid-19 patients and
containment centers.
11
LAURUS Labs
Knowledge Innovation. ExcelenceView entire presentation